Medical Research
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
Large population study finds SABR linked to higher three-year mortality than surgery, but gap narrows significantly for patients 80 and older.
-
Researchers find biological clues to why colorectal cancer strikes young adults
A new cell-by-cell tumor atlas sheds light on the aggressive nature of colorectal cancer in younger populations as screening rates expand.
-
Penn study finds patient navigators overcome hidden asthma barriers
A new trial shows trained navigators help low-income adults manage environmental and social obstacles, improving asthma control.
-
Blood Cancer UK launches £25m appeal to double leukaemia survival rates
Scientists aim to double leukaemia survival rates using a pioneering multi-treatment clinical trial method that previously transformed prostate cancer care.
-
Flawed Studies Prompt Hormone Therapy Caution for Breast Cancer Survivors
Recent reevaluations of past studies suggest hormone therapy may be safer for breast cancer survivors than previously thought, but doctors remain cautious.
-
Dendritic Cell Cancer Vaccines: One FDA Approval, Most Others Still in Trials
Only sipuleucel-T is approved for advanced prostate cancer; private clinics like Immunocine in Mexico sell personalized dendritic cell therapies still in clinical…
-
CAR-T Cell Therapy Explained: How It Works, Approved Blood Cancers, and Key Risks
An oncologist’s viral reel calls it revolutionary; here is the plain guide to the treatment, its FDA-approved uses, response data, and serious…
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
Phase 1 trial of OSK gene therapy in three glaucoma patients finds no serious side effects and preliminary visual field improvements at…
-
Fulvic Acid and Cancer: What the 14-Hour Melanoma Study Actually Found
A viral reel cites a 2022 lab study on melanoma cells. Here is what it tested, what it found and what it…
-
Enoki Mushrooms and Cancer: What Mouse Studies and Nagano Data Really Show
Animal trials used purified extracts to boost immunity in mice, while a 1989 Japanese study linked lower cancer rates in farmers to…
-
Understanding CIPI: Envita Medical Centers’ In-Tumor Injection Treatment
A neutral explainer detailing what Chemo Immuno Precision Injections are, how the procedure works at Envita Medical Centers, and its evidence status.
-
Epigenetic Clocks: Measuring Biological Age and Predicting Mortality
LONDON, July 8 — The biological clock may be more than a metaphor. For over a decade, researchers have been building tools…
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
The 2026 AACR Cancer Progress Report highlights a rise in survival rates and the emergence of innovative drug classes like PROTACs and…
-
How a Hidden Fat-Sensing Protein Could Unlock Immunotherapy for Deadly Colorectal Cancers
A new study reveals how tweaking a single molecular switch in immune cells could turn ‘untreatable’ tumors into immunotherapy responders—without headlines.
-
How Texas’ $6B CPRIT Outpaces NIH in Speeding Cancer Breakthroughs
The state’s aggressive funding model recruits top researchers and accelerates treatments—while federal grants face slower bureaucratic hurdles.
-
Generalized Myasthenia Gravis: Autoimmune Attack on Nerve-Muscle Junction Causes Progressive Weakness
Generalized myasthenia gravis is an autoimmune disorder where antibodies destroy acetylcholine receptors, leading to muscle weakness that worsens with activity and improves…
-
FDA Approves Zanvastro, the First Drug for the Rare Brain Disorder Alexander Disease
Madison, October 16 — The US Food and Drug Administration has approved Zanvastro, the first drug designed to directly treat Alexander disease,…
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
The landmark trial published in NEJM found Dexcom G7 users achieved 0.9% greater A1C reduction versus routine care, with five more hours…
-
Cancer Researchers Face Funding Gaps and Scientific Hurdles as Personal Stories Drive Public Support
Despite rising prevention knowledge and fundraising success, scientists cite funding instability and complex tumor biology as key barriers to progress in cancer…
-
FDA expands Anktiva approval to cover papillary-only bladder cancer, first treatment for this group
The FDA has broadened Anktiva’s use with BCG to include patients with BCG-unresponsive, high-grade papillary-only non-muscle-invasive bladder cancer, offering a bladder-preserving option…
-
Stanford-Developed Orca-T Wins FDA Approval as First Regulatory T Cell Therapy for Blood Cancer Transplants
STANFORD, October 10 — Stanford Medicine administered the world’s first commercial dose of Orca-T on October 7, 2026, marking the therapy’s debut…
-
GammaTile Trial Shows 1.3% Recurrence at One Year Versus 15.4% After Standard Radiation
HOUSTON, October 2 — GT Medical Technologies announced on September 29, 2026, that the results of the randomized, multicenter ROADS trial (NCT04365374)…
-
Immunotherapy Emerges as the Fourth Pillar of Cancer Care, Experts Say
ISLAMABAD, September 20 — Cancer immunotherapy, the approach that harnesses the body’s own immune system to fight tumours, has become the fourth…
-
Autism Test ADOS-2 Can Miss Girls, Studies Find
ANN ARBOR, August 2 — The Autism Diagnostic Observation Schedule, known as ADOS-2, stands as a cornerstone in the diagnosis of autism…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992